Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HIF-1α-IN-4 is an inhibitor of HIF-1α with IC50 of 24 nM in HEK293T cells which has potential antitumor effects. HIF-1α-IN-4 downregulates VEGF and PDK1 mRNA expressions under hypoxia [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | HIF-1α-IN-4 is an inhibitor of HIF-1α with IC50 of 24 nM in HEK293T cells which has potential antitumor effects. HIF-1α-IN-4 downregulates VEGF and PDK1 mRNA expressions under hypoxia [1]. |
In vitro | HIF-1α-IN-4 (compound 31, 24h) demonstrates inhibitory activity on HIF-1α transcription in HEK293T cells, exhibiting an IC50 of 24 nM [1]. Additionally, at concentrations ranging from 0-50 μM over 24 hours, it dose-dependently diminishes the expressions of VEGF and PDK1 mRNA in HEK293T cells under hypoxic conditions, as evidenced by RT-PCR [1]. |
Molecular Weight | 280.28 |
Formula | C16H12N2O3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.